EUVIMEDObjevte EUVIMED
EditorialOpen access

Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply

Takashi Kumada iD, Masanori Atsukawa iD, Taeang Arai iD, Hidenori Toyoda iD, Junko Tanaka iD

Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (3) · 406-407

DOI: 10.1111/apt.70754 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-05-22. Written by Takashi Kumada and 4 co-authors. Institution: Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan. 10 references. The full text is freely available in PubMed Central.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Authors and institutions

  • Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
  • Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
  • Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.

ORCID profiles: Takashi Kumada, Masanori Atsukawa, Taeang Arai, Hidenori Toyoda, Junko Tanaka

Cite

APA

Kumada, T., Atsukawa, M., Arai, T., Toyoda, H., & Tanaka, J. (2026). Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(3), 406-407. https://doi.org/10.1111/apt.70754

Vancouver

Kumada T, Atsukawa M, Arai T, Toyoda H, Tanaka J. Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(3):406-407. doi:10.1111/apt.70754

BibTeX
@article{Kumada2026,
  author = {Kumada, Takashi and Atsukawa, Masanori and Arai, Taeang and Toyoda, Hidenori and Tanaka, Junko},
  title = {Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline—A Step Towards Functional Cure or a Marginal Margin? Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {3},
  pages = {406--407},
  doi = {10.1111/apt.70754}
}
Start for free →